Loading...

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice

Background: The non-homogenous distribution of antibody-drug conjugates (ADCs) within solid tumors is a major limiting factor for their wide clinical application. Nanobodies have been shown to rapidly penetrate into xenografts, achieving more homogeneous tumor targeting. However, their rapid renal c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Theranostics
Main Authors: Xenaki, Katerina T, Dorresteijn, Bram, Muns, Joey A, Adamzek, Kevin, Doulkeridou, Sofia, Houthoff, HendrikJan, Oliveira, Sabrina, van Bergen en Henegouwen, Paul MP
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039960/
https://ncbi.nlm.nih.gov/pubmed/33859761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.57510
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!